GlassScriptPhysician profile
James R Parker
NPI 1891737979
$2,141.42
in general payments reported to CMS, 2019-2025
15 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $248 · 2021: $558 · 2022: $162 · 2023: $323 · 2024: $51.76 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $649.92 | 2019-2025 | 1688, Cinchlock |
| Abbott Laboratories | $365.21 | 2019-2023 | Proclaim |
| Smith+Nephew, INC. | $196.79 | 2021-2023 | Bone Anchors With Arthroscopic Delivery System |
| Zyla Life Sciences, INC. | $193.28 | 2019 | |
| Rattan and Associates | $143.12 | 2019 | |
| Depuy Synthes Sales INC. | $132.57 | 2020-2024 | Na, Lcp, Monovisc |
| Vertex Pharmaceuticals Incorporated | $121.53 | 2024-2025 | |
| Horizon Therapeutics Plc | $97.61 | 2019-2021 | |
| Arthrex, INC. | $78.60 | 2022 | |
| Bioventus LLC | $46.92 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $39.98 | 2023 | Seglentis |
| Baudax Bio INC. | $20.49 | 2021 | |
| Pfizer INC. | $19.10 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.43 | 2025 | Exparel |
| Ethicon US, LLC | $17.87 | 2024 | Dermabond Prineo, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.